Xeris Biopharma Holdings, Inc. (XERS) › Operating Cash FlowXeris Biopharma Holdings, Inc. (XERS) — Operating Cash FlowAnnual figures by period end, from SEC filings.2020-12-31: -$80.56M2021-12-31: -$95.53M2022-12-31: -$102.89M2023-12-31: -$47.02M2024-12-31: -$36.98M2025-12-31: $28.63M$28.63M2020-12-31Operating Cash Flow (USD)2025-12-31Period endedOperating Cash FlowChange YoYSource filing2025-12-31$28.63M—2026-03-02From 2025-01-012024-12-31-$36.98M—2026-03-02From 2024-01-012023-12-31-$47.02M—2026-03-02From 2023-01-012022-12-31-$102.89M—2025-03-06From 2022-01-012021-12-31-$95.53M—2024-03-06From 2021-01-012020-12-31-$80.56M—2022-03-11From 2020-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)